Potent Suppression of HIV Type 1 Infection By a Short Hairpin Anti-CXCR4 siRNA
- 1 August 2003
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 19 (8) , 699-706
- https://doi.org/10.1089/088922203322280928
Abstract
The phenomenon of RNA interference (RNAi) sparked a new surge in the area of posttranscriptional gene silencing methodologies and their potential application for HIV-1 gene therapy. A potentially promising strategy is to exploit siRNAs to prevent viral entry at the cell surface by down-regulating essential cell surface HIV-1 coreceptors. In the present studies we targeted the CXCR4 coreceptor for disruption with siRNA to inhibit HIV-1 entry as a first step toward the ultimate goal of translating this to gene therapy for AIDS. A stem-loop hairpin structured anti-CXCR4 siRNA was designed and synthesized in vitro by transcription with T7 polymerase. Down-regulation of the coreceptor was assayed in U373-Magi-CXCR4 cells. FACS analysis showed marked down-regulation of CXCR4 on the cell surface and Western blot analysis confirmed the reduced levels of intracellular synthesis. When challenged with X4-tropic HIV-1 NL4-3, the siRNA-transfected cells exhibited marked viral resistance. Consistent with these results, siRNA-transfected primary lymphocytes also exhibited significant resistance to HIV-1 entry. These proof-of-concept studies demonstrated the efficacy of an siRNA targeted to an essential cellular coreceptor CXCR4 in protecting from HIV-1 infection. Delivery of this siRNA into hematopoietic stem cells via lentiviral vectors may have potential gene therapeutic applications.Keywords
This publication has 34 references indexed in Scilit:
- RNA interferenceNature, 2002
- Modulation of HIV-1 replication by RNA interferenceNature, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cellsGenes & Development, 2002
- A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAS, and trans-dominant negative mutant gag and env proteinsFrontiers in Bioscience-Landmark, 2002
- RNA interference—2001Genes & Development, 2001
- Downregulation of the CCR5 β-Chemokine Receptor and Inhibition of HIV-1 Infection by Stable VA1-Ribozyme Chimeric TranscriptsAntisense and Nucleic Acid Drug Development, 2000
- Characterization of Anti-CCR5 Ribozyme-Transduced CD34+ Hematopoietic Progenitor Cells in Vitro and in a SCID-hu Mouse Model in VivoMolecular Therapy, 2000
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4Cell, 1996